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Background: Children with congenital Zika syndrome (CZS) have a 
wide range of additional healthcare needs. This study aimed to 
estimate the direct costs of CZS from the health provider and family 
perspectives, and the indirect costs for families, in two Brazilian states: 
Rio de Janeiro and Pernambuco. 
  
Methods: A case-control study was undertaken between May 2017-
January 2018 recruiting 174 cases with severe CZS, 41 with 
mild/moderate CZS and 269 children with no CZS, across the two sites, 
from existing studies. The primary caregiver was interviewed using a 
structured questionnaire to collect information on healthcare use and 
costs incurred during the previous 12 months. In Rio de Janeiro, 
health care utilization data was also extracted from electronic medical 
records. We estimated direct and indirect costs incurred as a result of 
CZS from the perspective of the health system and families. 
 
Results: Children with CZS accessed more healthcare facilities and 
reported longer travel and waiting times than children unaffected by 
CZS. Total costs from the health provider perspective of outpatient 
visits, were highest for children with severe CZS (U$1,411) followed by 
children with mild/moderate CZS (U$264) and children without CZS 
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(U$107). This pattern was apparent for direct costs incurred by 
families, while median indirect costs were low. Families of children 
with CZS reported high levels of catastrophic expenditures; Expenses 
incurred by families to meet their child’s needs as a proportion of 
household income was 30% (IQR=14%-67%, p<0.01) for children with 
severe CZS, 11% (IQR=4%-33%, p<0.01) for mild/moderate CZS, and 1% 
(IQR=0%-8%) for controls. Costs incurred by families were generally 
higher in Rio de Janeiro than Pernambuco. 
  
Conclusions: Families of children affected by CZS in Brazil may need 
additional public health resources and social benefits to protect them 
from incurring catastrophic expenses while meeting the needs of their 
children.
Keywords 
Congenital Zika Syndrome, Brazil, case-control study, economic, 
expenditure, costs, impact
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Introduction
In 2016, the world health organization (WHO declared the 
Zika virus (ZIKV) epidemic a “public health emergency of 
international concern”, because of its association with a wide 
spectrum of congenital anomalies, now collectively called 
“congenital Zika syndrome” (CZS)1. Brazil was the most severely 
affected among the countries and territories reporting out-
breaks; by 2018 there were 2,952 cases of “confirmed congenital 
syndrome associated with Zika virus infection” in Brazil, 
making up 79% of cases for the PAHO region2. The true 
number is likely to be far higher. ZIKV spread throughout all 
Brazilian regions, but the epicenter of the epidemic was in the 
Northeast region3,4.
Microcephaly is the most severe CZS complication in 
children, but congenital infection with ZIKV is also associ-
ated with a range of other conditions, including hypertonic-
ity, seizures, ophthalmic abnormalities, arthrogryposis, cardiac 
conditions and early development delay5–7. Consequently, 
children with CZS are likely to experience a wide range of 
additional health and social needs during their lifetime, includ-
ing for specialized health care and education8. Moreover, 
families of children with CZS can experience substantial 
financial impacts, as they try to meet the needs of their child, 
for instance paying for travel to receive healthcare or pur-
chasing assistive technologies. Additionally, mothers often 
assume the role of the main caregiver and may not return to 
employment9.
The outbreak of ZIKV in Brazil occurred in the middle of 
an economic crisis that began in 2014 and resulted in a set of 
fiscal austerity measures implemented from 2016, including 
freezing the social and health care spending10. The national 
health system (Sistema Único de Saúde - SUS) provides uni-
versal health care with its services financed and delivered at the 
federal, state and municipal level. While total public health 
expenditure per capita by municipalities grew by 226% from 
2003 to 2014, it has decreased by 6.3% since 201511. Provi-
sion of efficient and effective healthcare services tailored to 
children affected by CZS is therefore challenging for the SUS, 
due to the funding constraints and the high and diverse needs 
of the children for public resources, including for a broad 
range of medical specialties and technologies.
To date, the economic impact of CZS for families and the 
health provider is unknown. One model created to inform a 
cost-effectiveness tool, by AlfaroMurillo et al., predicted 
that each case of microcephaly incurs direct medical costs of 
$91,102 and $28,818 over the lifetime for Latin America and 
the Caribbean, respectively12. However, these results were 
estimated by extrapolating the costs of a case of intellec-
tual disability from the United States, and actual data has not 
been generated for the Zika epidemic. Other analyses have 
focused on the economic burden of microcephaly in the USA, 
but the findings may not be relevant to Brazil or other Latin 
American settings13. The lack of data on economic impacts 
of CZS is an important gap, as understanding the social 
and economic consequences of CZS in Brazil could help 
decision-makers in allocating optimal resources to support 
these children’s healthcare and social needs. 
The aim of this study was to estimate the direct cost of caring 
for a child with CZS from the health provider perspective and 
the direct and indirect cost for families over a 12 month period, 
in two Brazilian settings: Rio de Janeiro city, capital of the 




A case-control study was carried out in two contrasting sites 
in Brazil, selected from where research was ongoing and the 
teams had good access to families of children with CZS14. 
The first was Recife city and Jaboatão dos Guararapes, in the 
State of Pernambuco in Northeast Brazil. The Northeast region 
has a high number of suspected and confirmed cases of CZS 
and is considered the epicenter of the epidemic. For con-
trast, the second site was Rio de Janeiro city, in the state of Rio 
de Janeiro, where symptomatic ZIKV was less prevalent and 
reports of CZS far lower. Collectively, the States of Rio de Janeiro 
and Pernambuco accounted for 25% of confirmed CZS cases 
in the country4. Furthermore, Rio de Janeiro and Pernambuco 
have among the largest public health care networks in Bra-
zil, with most of hospitals and outpatient facilities linked to 
the SUS15,16. The protocol of the study has been published 
in full previously14.
Children in the study were born from late 2015 through 2016. 
Economic data (health provider costs, and direct and indi-
rect costs incurred by the families) was collected between May 
2017 and January 2018 through use of a questionnaire com-
pleted by the child’s caregiver and electronic medical records 
(Rio de Janeiro only).
Cases and controls
In Pernambuco, the majority of cases and controls were iden-
tified from an existing case-control study initiated in January 
201617. In Rio de Janeiro, the main source of the cases and 
controls was from an ongoing cohort study.
Case selection. In Pernambuco, cases were children born 
with microcephaly, head circumferences < 2 standard devia-
tions (SD) than the mean in eight public maternity hospitals. 
Additional cases with microcephaly were identified from an 
ongoing cohort of pregnant women who presented with a 
rash (a common symptom of ZIKV infection), and from out-
patient clinics of children with CZS (mostly from Oswaldo 
Cruz hospital). They were classified as severe or moder-
ate CZS, based on their head circumference (“severe” head 
circumference <3 SDs below the mean for age and sex).
In Rio de Janeiro, the source of the cases was the Verti-
cal Exposure to Zika Virus and Its Consequences for Child 
Neurodevelopment: Cohort Study in Fiocruz/IFF (Clinical-
Trials.gov Identifier: NCT03255369). Cases were children 
born to mothers known to be ZIKV positive, who either 1) 
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had microcephaly or significant developmental delay (i.e. 
had a composite score <70 on the Bayley Scale of Infant 
Development scale18 between 6 and 36 months) and presented 
with other clinical conditions with eye or hearing abnormali-
ties or other brain malformations (“Severe CZS”), or 2) had less 
severe developmental delay indicated by a composite Bayley 
score of 70–84 (“Mild/moderate CZS”).
Control selection. In Pernambuco, controls were children born 
in the same hospitals, but without microcephaly and without 
neurological or other health problems (determined from trans-
fontanelle ultrasonography, and through physical examina-
tion by the study neonatologist), with both examinations 
performed soon after birth17. Controls were matched to cases 
on the basis of expected date of delivery and place of mother’s 
residence (by health region). During the follow-up interview in 
2017/2018, parents were asked whether there were any devel-
opmental delays (using the Denver Developmental Screening 
Test)19, and if the response was positive, they were excluded 
from the study and referred for further investigation.
In Rio de Janeiro, control subjects were born to mothers with-
out a history of symptoms and without developmental delay, 
as shown by: 1) a composite Score ≥85 on the Bayley Scale of 
Infant Development scale18, conducted between 6 and 36 months 
following the recommended guidelines and/or 2) assessment 
by two paediatricians based on the child’s medical records14. 
In Rio de Janeiro, the sample of controls included nine pairs of 
twins and, for each pair, one child was randomly selected 
for inclusion as a control, in order to avoid double-counting 
of families.
According to case and controls definitions, children in both 
settings were categorized into three groups: (1) children with 
severe CZS (microcephaly or with serious developmental 
delay); (2) children with mild/moderate CZS; and (3) children 
not affected by CZS.
Sample size justification
The sample size for the overall study was powered to detect a 
difference in depression prevalence between the control and 
case mothers, as this was one of the study’s primary 
outcomes14. We aimed to recruit 100 cases and 100 controls 
per setting, which would provide the power to detect an odds 
ratio (OR) of 2.6 in each site for the association between depres-
sion and CZS, assuming 95% confidence, 80% power and a 
prevalence of depression of 15% in unaffected mothers. 
Across the two samples (i.e. 200 cases and 200 controls), the 
sample size would be adequate to detect an OR of 2.1 for the 
same association. We considered that the sample size would 
be sufficient for the current analyses, given the large expected 
economic impacts of CZS. 
Data collection
Two sources of data were used to estimate the direct and 
indirect costs of CZS. 
First, the primary caregiver (usually the mother) was 
interviewed using a semi-structured questionnaire, between 
May 2017 and January 2018 (full questionnaire available as 
extended data20. Data were collected on socio-economic status, 
clinical data, direct costs (e.g. travel, food, parking, hospital/
exam fees) and indirect costs from families and main caregiver 
(e.g. productivity loss/opportunity cost), health care resource 
utilization (frequency of outpatient visits to different types 
of health professionals, and number of hospitalizations), and 
coping strategies (selling of assets, borrowing money). The 
effort of the caregiver in seeking care was also estimated by 
asking about the number of healthcare facilities where the 
child received care, transportation time and waiting time at 
the health care facility for a typical visit. The reference period 
was the last 12 months. The cost component of the question-
naire used a tool developed by the UK working party on patient 
costs as a template and adjusted it to the context21. 
Additionally, the questionnaire was used to collect data from 
the caregiver on the family monthly income and other socio- 
demographic characteristics, as well as parental indica-
tors (e.g. age, marital status, schooling, depression, anxiety 
and stress, social support). For analysis, monthly income was 
converted into yearly income.
The second data source was the CZS cohort´s electronic 
medical records database that recorded resource utilization 
(hospitalizations, tests and exams) for each child in the Rio 
de Janeiro sample, between June 2016 and April 2018. Hos-
pital data from electronic medical records that included 
hospitalizations, tests and exams were not available for 
Pernambuco. 
Calculation of health provider’s costs
Costs from the national health system perspective were cal-
culated using an ingredient approach for each child and 
each year, whereby each resource used was identified, quanti-
fied and valued. The number of consumed resources (outpatient 
visits, hospitalizations, and tests) were multiplied by the costs 
on the national cost reference table and adjusted by a factor 
of x3.51, as suggested in the literature22,23. This factor was esti-
mated by an analysis of the cost of some procedures, as the 
national cost reference table did not reflect the real cost of 
these procedures as it had not been updated for approximately 
eight years. 
The number of consumed resources for outpatient visits, 
hospitalization and tests and exams were estimated as follows:
-    Medical appointments: The number of outpatient visits 
were collected from the questionnaire for both settings and 
included a broad range of specialties (e.g. genetics, neurology, 
nutrition, occupational therapy, ophthalmology, orthopaedics, 
paediatrics, physiotherapy, and audiology). The costs of these 
were estimated from the national cost reference table, with 
adjustment. 
-    Hospitalizations: The number of hospitalizations were collected 
from the questionnaire. For Rio de Janeiro, the electronic hos-
pital database contained information on all procedures under-
taken for these hospitalization events, which included surgical 
(e.g. gastrostomy tubes) and non-surgical procedures 
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(e.g. pneumonia treatment). These interventions were costed 
using the national cost reference table, with adjustment. We 
assumed that the mean medical direct cost of hospitalization 
by group of cases in Rio de Janeiro was a proxy of the cost 
in Pernambuco. 
-    Tests and exams: Tests and exams received were available for 
the children in the Rio de Janeiro arm of the study from the 
electronic hospital database, and these included reverse tran-
scription polymerase chain reaction (RT-PCR), eye exami-
nation, hearing examination, fat and free mass composition, 
composite Bayley test18, laboratory tests, and brain images 
(transfontanelle cerebral ultrasonography, computed tomogra-
phy, and magnetic resonance imaging). The costs of these tests 
were estimated from the national cost reference table, with 
adjustment, except for the costs of RT-PCR, fat and free 
mass composition and composite Bayley test which were 
not included in the national cost reference table. Therefore, 
micro-costing was applied to estimate their costs using inputs 
from the from Brazilian government price databases and local 
suppliers. We did not include test and exam costs of children 
in the Pernambuco arm of the study. 
All costs were converted into U$ 2017 at the exchange rate 
of 3.19 Brazilian reais/U$ (www.http://data.imf.org). No dis-
counting or inflation rate adjustments were applied. Costs were 
annualized when necessary.
Calculation of family costs
Direct, and indirect costs incurred by the family were 
collected through the questionnaire.
-    Direct costs included all out-of-pocket expenditure (food at 
healthcare facility, drugs, special milk formulas, glasses, and 
other health care expenses, as well as transportation, costs 
associated with family displacement from their home and the 
renovation of the patient’s home). Costs were defined as 
catastrophic expenditures if total direct costs were equal or 
above 40% of yearly household income (estimated using the 
Critério Brasil based on assets and infrastructure of the 
household)24.
-    Indirect costs included the productivity loss of the caregiver 
and were estimated as the days of work lost to take care of 
the child, the time invested in transportation and the waiting 
time seeking for health services. The value of one workday 
was estimated using the median of household income provided 
by Critério Brasil divided by the number of persons living in 
the house and monthly working days. Coping costs (selling of 
assets and borrowed money) were measured through the ques-
tionnaire in order to understand how families handle these 
expenses. 
Costs were calculated for a 12-month period. For children 
aged less than 12 months at interview, an extrapolation was 
made for the full 12 months based on monthly consumption 
data available. 
Data analysis
Median and interquartile range (IQR), for continuous data and 
frequency distributions for categorical variables were used 
to describe the study sample, effort of main caregiver, and 
direct and indirect costs, all stratified by age, location and group 
(severe CZS, mild/moderate CZS no CZS).
Cost data was statistically analysed using the Kolmogorov-
Smirnov test to assess the normality assumption. Differences 
between groups were verified through a pairwise compari-
son using the student’s t-test and the Wilcoxon-Mann-Whitney. 
We also used chi-square test to compare categorical variables 
of effort of main caregiver between the groups. A 5% level 
was chosen as the level of significance. Data management 
and statistics analysis were performed using R (R Core Team. 
Foundation for Statistical Computing V, Austria, version 3.2.2) 
and Microsoft Excel (version 16.45). Costs were estimated 
for a one year period from the child birth date (i.e. the time 
horizon), and the year of analysis was 2017. 
Ethical considerations
Ethical approval for the study was received from London 
School of Hygiene and Tropical Medicine (LSHTM) and the 
Fiocruz ethics committee (CAAE 60682516.2.1001.5269). 
All interviewees were adults and provided written informed 
consent, as outlined previously14.
Results
Characteristics of study subjects
A total of 484 main caregivers were interviewed, 56% 
from Rio de Janeiro and 44% from Recife (Table 1). Of the 
484 children, 36% (n=174) had severe CZS, 9% (n=41) mild/ 
moderate CZS and 56% (n=269) were children not affected 
by CZS. The sample was made up of approximately equal 
numbers of boys and girls. Most of the children (70%) were 
more than one year old at the time of the interview. In Rio 
de Janeiro the children with severe CZS were on average 
younger than the those with no CZS, while in Pernambuco the 
opposite was true. Approximately half of the children lived 
outside of the cities of Rio de Janeiro and Recife. Moth-
ers were the main caregivers for more than 93% of children. 
Overall and in Rio de Janeiro caregivers of children with severe 
CZS were generally younger than control caregivers, while in 
Pernambuco the groups were well matched on age. A high pro-
portion of all caregivers lived with their partner (75%) and 
had nine or more years of education (82%). Overall, and 
in Rio de Janeiro, households of children with severe CZS 
were more likely to belong to the lowest socioeconomic class 
(39%) compared to controls (30%), but this difference was 
not observed in Pernambuco. The majority of households 
of children with severe CZS were receiving social benefits 
(62%), while this was less common in households of chil-
dren with mild/moderate (34%) or no CZS (29%). Receipt of 
social benefits was more common in Pernambuco than Rio de 
Janeiro, across all three groups. Households were relatively 
similar in terms of household size and number of children, 
regardless of location and CZS status. 
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Table 1. Baseline characteristics of the study children and families stratified by location (Rio de Janeiro and 
Pernambuco) and group (severe CZS, mild/moderate CZS and no CZS), Brazil.



























Female 51% 61% 49% 45% 47% 52% 57% 32% 45%
Male 49% 39% 51% 55% 53% 48% 43% 68% 55%
Age (years)
< 1 year 32% 24% 30% 50% 16% 31% 11% 32% 29%
≥ 1 year 68% 76% 70% 50% 84% 69% 89% 68% 71%
Residence
Within the city (Rio/Recife) 45% 52% 55% 42% 58% 52% 47% 46% 61%
Outside city 55% 48% 45% 58% 42% 48% 53% 55% 39%
Main caregiver
Mother 97% 97% 93% 98% 100% 96% 96% 96% 90%
Father 1% 0% 1% 1% 0% 1% 0% 0% 0%
Others 2% 3% 6% 1% 0% 3% 4% 4% 10%
Age (years)
<25 40% 22% 28% 44% 5% 22% 37% 36% 36%
25–34 47% 37% 49% 48% 42% 49% 45% 32% 48%
≥ 35 13% 41% 23% 8% 53% 29% 18% 32% 16%
Marital Status
Living as a couple 71% 93% 75% 71% 95% 81% 71% 91% 68%
Living alone 29% 7% 22% 29% 5% 19% 28% 9% 26%
Not Answered 0% 0% 3% 0% 0% 0% 1% 0% 6%
Schooling (years)
<9 23% 10% 16% 19% 0% 11% 28% 18% 24%
≥ 9 77% 90% 84% 81% 100% 89% 72% 82% 76%
Household
Socio-economic statusa
A (highest) 0% 2% 2% 0% 5% 2% 0% 0% 1%
B 13% 32% 17% 19% 53% 27% 5% 14% 4%
C 49% 34% 51% 53% 37% 55% 44% 32% 45%
D-E (lowest) 38% 32% 30% 28% 5% 16% 51% 54% 50%
Receive social benefits 62% 34% 29% 48% 22% 16% 75% 40% 43%
Size (persons)
≤ 3 42% 49% 36% 44% 47% 40% 41% 50% 31%
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Effort in seeking healthcare by the main caregiver
In the previous year approximately half of children with 
severe CZS (56%) and with mild/moderate CZS (44%) had to 
access at least three health care facilities, while utilization of 
three facilities was much rarer among children with no CZS 
(7%) (Table 2). Time taken to reach the healthcare facility for 
families of children with severe CZS was frequently more than 
three hours (46%), while this proportion was lower among 
children with mild/moderate CZS (20%) or no CZS (28%). 
Waiting time at the health care facility was often more than 
three hours, across the three CZS groups. These patterns were 
consistent in both Pernambuco and Rio de Janeiro, except 
effort scores were particularly low among the “no CZS” group 
in Pernambuco. 
Health provider costs
The median health provider cost of outpatient visits for chil-
dren with severe CZS (U$1,411, IQR 740-2,060) were 
significantly higher than children with mild/moderate CZS 
(U$264, 174-1,144, p<0.01) and those not affected by CZS 
(U$107, 74-209, p<0.01) (Table 3). Similarly, cost of tests 
and examinations (estimated only for Rio de Janeiro) were 
higher among children with severe CZS (U$637, 291-966) 
compared to mild/moderate CZS (U$179, 101-491, p<0.01) 
or no CZS (U$ 373, 119-644, p=0.04) groups. Median hospi-
talization costs were U$288 (0-661) for children with severe 
CZS, but U$0 for the other two groups (p<0.01 for both com-
parisons). Costs of visits and hospitalizations were significantly 
higher for children with mild/moderate CZS than no CZS. 
These patterns were broadly similar when stratified by loca-
tion, although data on costs of tests and exams were not 
available for Pernambuco.
Family direct and indirect costs
Table 4 shows the direct and indirect costs incurred by fami-
lies for each group of children. Total direct costs for food, 
transport or other items, were consistently higher for chil-
dren with severe CZS (total U$1,129) compared to those with 
mild/moderate CZS (total U$231), which in turn were higher 
than for children with no CZS (total U$38). These pat-
terns for direct costs were consistent in Rio de Janeiro and 
Pernambuco, although costs were generally higher in Rio de 
Janeiro, in particular transport costs. Median indirect costs 
were generally low. Productivity costs were higher for fami-
lies with children with CZS compared to children without CZS. 
Stratification by location revealed more substantive indirect 
costs associated with Severe CZS in Rio de Janeiro, but that in 
the other groups and in Pernambuco these costs remained low.
Families of children with severe and mild/moderate CZS 
reported high levels of catastrophic expenditures considering 
the direct and indirect costs incurred by them during the care 
of their child. Expenses incurred by families as a proportion 
of household income was 30% (IQR=14%-67%) for children 
with severe CZS, 11% (IQR=4%-33%) for those with mild/
moderate CZS, and 1% (IQR=0%-8%) for families of 
children not affected with CZS (p<0.01 for each comparison). 
In Rio de Janeiro, these figures were 34% (IQR=18%-68%) 
for families of children with severe CZS, 9% (IQR=5%-29%) 
for those with mild/moderate CZS, and 8% (IQR=3%-22%) for 
families of children not affected CZS. In Pernambuco, these 
figures were 27% (IQR=11%-67%) for families of children with 
severe CZS, 13% (IQR=4-45%) for those with mild/moder-
ate CZS reported and 0% (IQR=0%-1%) for families of children 
not affect by CZS. 
Discussion
The main purpose of our study was to estimate the direct and 
indirect costs of caring for children with CZS, from the fam-
ily and health provider perspective, based on a study carried out 
in Rio de Janeiro and Pernambuco. This analysis was based 
on three groups of children, selected to represent the broad 

























4–5 44% 37% 52% 43% 37% 50% 44% 36% 55%
≥ 6 14% 14% 12% 13% 16% 10% 15% 14% 14%
Additional childrenb
0 52% 61% 52% 52% 53% 56% 50% 68% 46%
1 33% 29% 32% 33% 42% 31% 33% 18% 34%
≥ 2 15% 10% 16% 15% 5% 13% 17% 14% 20%
CZS=congenital ZIKA syndrome
1 U$ = R$ 3.19 in 2017 average exchange rate.
a Household income was estimated according to Critério Brasil. A (mean family income: U$ 6,547.8); B (mean family income: B2 U$ 1,521.0 - B1 U$ 
2.900,94); C (mean family income: C2 U$ 509.4- C1 U$ 847.96); D-E (mean family income: U$ 240.75)
b Excluding the current one.
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spectrum of clinical presentations of this condition: children 
with severe, mild/moderate and no CZS. We also examined in 
depth the effort of the main caregiver in their interaction with the 
health care system, as children with CZS had a high consump-
tion of resources, likely to continue throughout their life-
time. To the best of our knowledge, this was the first study to 
quantify the costs incurred from caring for a child with CZS 
from the health provider and family perspectives using primary 
data.
This study showed that children with severe or mild/moder-
ate CZS accessed more healthcare facilities and reported longer 
travel and waiting times than children unaffected by Zika. 
Costs of outpatient visits were highest for children with severe 
CZS followed by children with mild/moderate CZS and chil-
dren without CZS, although there was some variation between 
the two settings. Direct and indirect costs incurred by families 
were higher for families of children affected by Zika, in partic-
ular as a result of “other” costs, such as drugs and special milk 
formula. 
Most of the main caregivers of children with CZS were 
mothers who experienced high time costs in seeking and access-
ing care for their children. One contributing factor to this 
high effort is that almost half of cases lived outside the met-
ropolitan area of Rio de Janeiro and Recife and so healthcare 
services were situated far from households in both cities. The 
transportation costs incurred by caregivers were much higher 
in Rio de Janeiro than in Pernambuco, potentially because 
in the latter setting caregivers had access to public services 
provided by government to allow them to reach the health-
care facilities. Thus, given such high care needs in a context 
of fragmented health services provision, the coordination of 
the health system would be very helpful to caregivers, saving 
time and money25.
Our analysis also shows that many families of children with 
CZS in both settings faced catastrophic expenditures, using a 
threshold based on a multi-country study, that included 
Brazil24. Catastrophic health expenditures had a high poten-
tial to lead to impoverishment, considering that about 40% 
of families of children with severe CZS reported an average 
monthly income of U$ 240.75. This situation was exacerbated 
by the Brazilian economic crisis that has been experienced 
since 2014, through increase in unemployment and austerity 
measures leading to a reduction in social expenditures and 
cuts in the health budget. According to Brazilian public poli-
cies, these children should be guaranteed access to health care 
services and transport systems. However, the high costs 
incurred by families of children with CZS in transport and drugs 
show that this has not happened. The impoverishment 
of households in Brazil due to costs of drugs has been 
demonstrated previously for other conditions26. It is also appar-
ent that families of children with CZS should be given social 
benefits in order to reduce the financial impact experienced, 
yet at the time of the study only 62% of caregivers of children 
with severe CZS and 34% of those with mild/moderate CZS 
received social benefits. Enhancing and coordinating social 
and childcare policies is essential to support families in coping 
with the situation.
Another concern is that there are still gaps in services for 
children with CZS. Between 2015 and 2018, about 79% of 
children with CZS in Pernambuco had access to special-
ized health care services but only 35% in Rio de Janeiro4, and 
nutritional services are also reported to be inadequate for these 
children27. Gaps in access to required healthcare services pose 
specific issues that need to be addressed by policymakers, 
as they highlight the need for a well-structured health care 
network that caters to all levels of assistance and avoids car-
egivers of children with CZS having to access many different 
facilities to seek care. It is likely that provision of these serv-
ices will push the costs of caring for a child with CZS higher 
still but may also improve health status and thereby protect 
from other health care costs. 
Meeting these costs will be challenging, since the current 
economic crisis in Brazil has meant that federal health spend-
ing will be limited over the next twenty years. The annual 
SUS budget was approximately USD $62 billion (USD$, 
2017) before the funding process changed in 2018. Early esti-
mates suggest that the SUS budget will suffer a cumulative loss 
of around U$190 billion between 2017 and 203628. Thus, the 
states and municipalities may need to increase their share of 
responsibility for funding SUS, although this seems difficult 
as the per capita expenditure has been declining since 201511. 
The economic crisis and austerity measures have been shown to 
impact negatively on social policies and contribute to the dete-
rioration of health care systems offering universal coverage29. 
This issue will be affected still further by the ongoing 
COVID-19 pandemic. The Brazilian health care system is fac-
ing scarcity of resources, inefficient resource allocation and 
uncoordinated care that could worsen the health outcomes 
of most vulnerable populations, such as children with CZS, 
even further.
There are few studies that provide cost analyses of CZS in coun-
tries where ZIKV have been recorded and that would allow 
comparison with our findings. A recent economic analysis 
in the US used the productivity costs associated with autism 
as a proxy to estimate the costs of microcephaly. However, 
results were likely to be substantially underestimated because 
the costs associated with autism are lower than those of 
microcephaly30. In another study, the lifetime medical costs 
of microcephaly to selected countries of Latin America and 
Caribbean amount to U$180,004 per case (in 2015 U$) and con-
sidered the costs associated with severe intellectual disability 
in the US in 200331. Both studies had to use assumptions to 
calculated costs of microcephaly because there is a dearth 
of previous estimates of the economic impact of microceph-
aly in many countries, and they lacked the primary data that 
we collected in the current study. A third study undertaken in 
Texas, USA also estimated high economic costs from inpa-
tient hospitalization for babies with microcephaly, which may 
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provide insights into a potential impact of Zika. However, it is 
hard to infer costs from USA to Brazil or other Latin American 
settings13.
There are several limitations of this study. The study was 
conducted in only two settings and therefore does not fully rep-
resent the entire country. Nevertheless, these states included 
25% of confirmed and suspected cases of CZS in Brazil4. 
In Pernambuco and Rio de Janeiro, attempts were made to include 
all eligible children with severe CZS, but inclusion of chil-
dren with mild/moderate CZS was less comprehensive and so 
they may not have been representative of cases in this cat-
egory overall. Additionally, the sample selection approach 
varied in the two sites, which may have influenced compara-
bility across Pernambuco and Rio de Janeiro. For instance, in 
Pernambuco the cases and controls were matched on loca-
tion while in Rio de Janeiro they were not, which explains in 
part the greater socio-economic differences between these 
groups in Rio de Janeiro than Pernambuco. Consequently, cases 
in Rio de Janeiro may have been more at risk of catastrophic 
expenditure than controls. Notwithstanding these differences, 
the expenditure by cases in Rio de Janeiro (whether severe 
CZS or mild/moderate CZS) were greater than in Pernam-
buco, and the difference in catastrophic expenditure between 
severe and no CZS groups similar in the two settings. Another 
limitation is that we did not consider costs associated with 
tests and exams in Pernambuco, due to the lack of hospi-
tal electronic medical record data, and this may bias our cost 
results. Furthermore, children were classified as having “no 
CZS” on the basis of tests and reports from when they were under 
two years of age. However, developmental delays may have 
become apparent as the child became older, and there is increas-
ing evidence that congenital infection with Zika may cause 
neurodevelopmental implications in children without CZS32. 
Consequently, some of the children in the “no CZS” group 
may have additional needs, and this may underestimate the 
true economic impact of CZS.
It is important to note, that while this study focused on 
economic costs, caring for a child with disabilities can have 
many positive outcomes. Furthermore, children with disabili-
ties have fundamental human rights, including access to health-
care. Our purpose in this paper is to encourage appropriate 
budgeting and planning of services, and not to put into 
question the need for healthcare investment in children with 
disabilities.
Conclusions
Children affected by CZS incurred greater costs, both from the 
perspective of the health provider and the family. This study 
supports the need for additional public health resources to 
meet the needs of those affected. Moreover, the magnitude of 
costs attributable to CZS for the families affected, and the high 
levels of catastrophic expenditure, shows a need to develop 
health related financial risk protection initiatives for house-




Data associated with this study will not be made freely 
available, owing to the small number of children with CZS, 
making data potentially identifiable, and the sensitive nature 
of the subjects discussed in the interviews. However, we are 
committed to collaborating with other researchers in the analy-
sis of our data (full questionnaire available online)14. Applica-
tions for access to the raw data for this study should be made 
by contacting Professor Hannah Kuper (hannah.kuper@lshtm.
ac.uk), Dr Tereza Maciel Lyra (terezalyra@cpqam.fiocruz.br) 
or Dr Maria Elisabeth Lopez Moreria (bebeth@iff.fiocruz.
br) and outlining the purpose of the proposed analyses and the 
variables requested. These applications will be reviewed by 
the three researchers, and if accepted, the requested variables 
will be shared.
Extended data
Open Science Framework: Social and Economic Impact of Con-
genital Zika Syndrome questionnaire. https://doi.org/10.17605/
OSF.IO/XJEP720.
This project contains the following extended data:
-  Questionnaire
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC-BY 4.0).
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